SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-072752
Filing Date
2023-12-22
Accepted
2023-12-22 17:20:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2023.12.22_defa14a.htm DEFA14A 80536
2 GRAPHIC img211577953_0.jpg GRAPHIC 11564
3 GRAPHIC img211577953_1.jpg GRAPHIC 14525
  Complete submission text file 0000950170-23-072752.txt   117752
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38958 | Film No.: 231510855
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)